
Katherine Peebles
Examiner (ID: 1636)
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617 |
| Total Applications | 624 |
| Issued Applications | 201 |
| Pending Applications | 121 |
| Abandoned Applications | 325 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16961525
[patent_doc_number] => 20210213024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => LIQUID COMPOSITIONS OF APREPITANT
[patent_app_type] => utility
[patent_app_number] => 16/967411
[patent_app_country] => US
[patent_app_date] => 2019-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967411
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967411 | LIQUID COMPOSITIONS OF APREPITANT | Feb 19, 2019 | Abandoned |
Array
(
[id] => 14567513
[patent_doc_number] => 20190211363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => Plant Activator Composition
[patent_app_type] => utility
[patent_app_number] => 16/279592
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16279592
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/279592 | Plant activator composition | Feb 18, 2019 | Issued |
Array
(
[id] => 17243844
[patent_doc_number] => 20210363587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => EPIGENETIC HISTONE REGULATION MEDIATED BY CXorf67
[patent_app_type] => utility
[patent_app_number] => 16/967993
[patent_app_country] => US
[patent_app_date] => 2019-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967993
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967993 | EPIGENETIC HISTONE REGULATION MEDIATED BY CXorf67 | Feb 5, 2019 | Abandoned |
Array
(
[id] => 16876792
[patent_doc_number] => 11026912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Azelaic acid esters in the treatment of insulin resistance
[patent_app_type] => utility
[patent_app_number] => 16/267338
[patent_app_country] => US
[patent_app_date] => 2019-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7155
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16267338
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/267338 | Azelaic acid esters in the treatment of insulin resistance | Feb 3, 2019 | Issued |
Array
(
[id] => 16548468
[patent_doc_number] => 10881605
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Methods for the preparation of injectable depot compositions
[patent_app_type] => utility
[patent_app_number] => 16/253486
[patent_app_country] => US
[patent_app_date] => 2019-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 48
[patent_no_of_words] => 24843
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16253486
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/253486 | Methods for the preparation of injectable depot compositions | Jan 21, 2019 | Issued |
Array
(
[id] => 16710268
[patent_doc_number] => 20210077415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => ORAL LIQUID PHARMACEUTICAL COMPOSITIONS OF AMINOSALICYLATES
[patent_app_type] => utility
[patent_app_number] => 16/959657
[patent_app_country] => US
[patent_app_date] => 2019-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959657
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959657 | ORAL LIQUID PHARMACEUTICAL COMPOSITIONS OF AMINOSALICYLATES | Jan 1, 2019 | Pending |
Array
(
[id] => 14990735
[patent_doc_number] => 20190314325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => Process and Method to Accelerate Cellular Regeneration, Healing and Wound Management
[patent_app_type] => utility
[patent_app_number] => 16/234799
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16234799
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/234799 | Process and Method to Accelerate Cellular Regeneration, Healing and Wound Management | Dec 27, 2018 | Abandoned |
Array
(
[id] => 14227241
[patent_doc_number] => 20190125793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => COMPOSITION COMPRISING CINNAMALDEHYDE AND ZINC TO IMPROVE SWALLOWING
[patent_app_type] => utility
[patent_app_number] => 16/233967
[patent_app_country] => US
[patent_app_date] => 2018-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16233967
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/233967 | COMPOSITION COMPRISING CINNAMALDEHYDE AND ZINC TO IMPROVE SWALLOWING | Dec 26, 2018 | Abandoned |
Array
(
[id] => 16726406
[patent_doc_number] => 20210093553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => NOVEL FORMULATIONS OF VASOPRESSIN
[patent_app_type] => utility
[patent_app_number] => 16/956631
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956631
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956631 | NOVEL FORMULATIONS OF VASOPRESSIN | Dec 20, 2018 | Abandoned |
Array
(
[id] => 14227227
[patent_doc_number] => 20190125786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => NOBLE GAS MODULATION OF IL-12
[patent_app_type] => utility
[patent_app_number] => 16/224083
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16224083
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/224083 | NOBLE GAS MODULATION OF IL-12 | Dec 17, 2018 | Abandoned |
Array
(
[id] => 15068283
[patent_doc_number] => 10463607
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-05
[patent_title] => Antipsychotic Injectable Depot Composition
[patent_app_type] => utility
[patent_app_number] => 16/220201
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 36
[patent_no_of_words] => 25737
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16220201
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/220201 | Antipsychotic Injectable Depot Composition | Dec 13, 2018 | Issued |
Array
(
[id] => 15225033
[patent_doc_number] => 10500220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Topical compositions
[patent_app_type] => utility
[patent_app_number] => 16/209542
[patent_app_country] => US
[patent_app_date] => 2018-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 17750
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16209542
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/209542 | Topical compositions | Dec 3, 2018 | Issued |
Array
(
[id] => 16310738
[patent_doc_number] => 20200289476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => LIQUID FORMULATIONS OF RILUZOLE FOR ORAL AND INTRAVENOUS USE
[patent_app_type] => utility
[patent_app_number] => 16/767706
[patent_app_country] => US
[patent_app_date] => 2018-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16767706
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/767706 | LIQUID FORMULATIONS OF RILUZOLE FOR ORAL AND INTRAVENOUS USE | Nov 27, 2018 | Abandoned |
Array
(
[id] => 14372359
[patent_doc_number] => 20190160092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => Advanced Functional Biocompatible Polymeric Matrix Used as a Hemostatic Agent and System for Damaged Tissues and Cells
[patent_app_type] => utility
[patent_app_number] => 16/195770
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16195770
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/195770 | Advanced Functional Biocompatible Polymeric Matrix Used as a Hemostatic Agent and System for Damaged Tissues and Cells | Nov 18, 2018 | Abandoned |
Array
(
[id] => 18043641
[patent_doc_number] => 11517574
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-06
[patent_title] => Linezolid formulations
[patent_app_type] => utility
[patent_app_number] => 16/764468
[patent_app_country] => US
[patent_app_date] => 2018-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16965
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16764468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/764468 | Linezolid formulations | Nov 15, 2018 | Issued |
Array
(
[id] => 14307183
[patent_doc_number] => 20190143295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/191487
[patent_app_country] => US
[patent_app_date] => 2018-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16191487
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/191487 | Nitric oxide containing composite | Nov 14, 2018 | Issued |
Array
(
[id] => 16869908
[patent_doc_number] => 20210163375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => COMPOSITION OF MICRONUTRIENTS AND ORGANIC COMPOUNDS FOR TREATING, COATING AND ENCRUSTING SEEDS
[patent_app_type] => utility
[patent_app_number] => 17/267917
[patent_app_country] => US
[patent_app_date] => 2018-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267917
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/267917 | COMPOSITION OF MICRONUTRIENTS AND ORGANIC COMPOUNDS FOR TREATING, COATING AND ENCRUSTING SEEDS | Nov 13, 2018 | Abandoned |
Array
(
[id] => 16310743
[patent_doc_number] => 20200289481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/760736
[patent_app_country] => US
[patent_app_date] => 2018-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760736
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/760736 | SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION | Oct 31, 2018 | Abandoned |
Array
(
[id] => 14156293
[patent_doc_number] => 20190105249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => UV-PROTECTIVE COMPOSITIONS AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/177477
[patent_app_country] => US
[patent_app_date] => 2018-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16177477
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/177477 | UV-PROTECTIVE COMPOSITIONS AND THEIR USE | Oct 31, 2018 | Abandoned |
Array
(
[id] => 16961503
[patent_doc_number] => 20210213002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => EXTERNAL PREPARATION FOR TREATING TRICHOPHYTOSIS UNGUIUM
[patent_app_type] => utility
[patent_app_number] => 16/760595
[patent_app_country] => US
[patent_app_date] => 2018-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760595
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/760595 | EXTERNAL PREPARATION FOR TREATING TRICHOPHYTOSIS UNGUIUM | Oct 28, 2018 | Abandoned |